Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|September 30, 2024

Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management

Author(s)Terry Faleye, MPAS, PA-C

Panelists discuss how to address treatment challenges and manage site-specific concerns in vitiligo patients, drawing on expert insights and clinical experience.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients

1 KOL is featured in this series.

EP. 2 Case-Based Discussion on Adherence, Adjunctive Therapy, and Simplifying Complex Regimens for Patients With Vitiligo

1 KOL is featured in this series.

EP. 3 Exploring Phototherapy, Combination Therapy, and Patient-Centered Approaches to Improve QOL for Patients with Vitiligo

1 KOL is featured in this series.

EP. 4 Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management

1 KOL is featured in this series.

EP. 5 Exploring Efficacy, Novel Mechanisms, and Patient Engagement in the Management of Vitiligo

1 KOL is featured in this series.

EP. 6 Vitiligo Treatment Paradigms: Clinician Experiences with Topical Ruxolitinib and Access Challenges

1 KOL is featured in this series.

EP. 7 Optimizing Vitiligo Management: Key Takeaways on Treatment Cycling and Ruxolitinib Use

EP. 8 Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1

EP. 8 Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Latest CME

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Trending on Dermatology Times

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

Introducing Dermatology Times NP/PA Connect